Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.

Research output: Contribution to journal › Comment/debate › peer-review

ASJC Scopus subject areas

@article{ff193edd30354cd0be3bf17477a8eb33,

title = "Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.",

author = "Mrugala, {Maciej M.}",

year = "2009",

month = feb,

day = "24",

language = "English (US)",

volume = "72",

pages = "773; author reply 773--774",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "8",

}

TY - JOUR

T1 - Bevacizumab for recurrent malignant gliomas

T2 - efficacy, toxicity, and patterns of recurrence.

AU - Mrugala, Maciej M.

PY - 2009/2/24

Y1 - 2009/2/24

UR - http://www.scopus.com/inward/record.url?scp=79959343234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959343234&partnerID=8YFLogxK

M3 - Comment/debate

C2 - 19248218

AN - SCOPUS:79959343234

SN - 0028-3878

VL - 72

SP - 773; author reply 773-774

JO - Neurology

JF - Neurology

IS - 8

ER -